Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
35 hedge funds and large institutions have $50.4M invested in Axcella Health Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.
5,880% more call options, than puts
Call options by funds: $299K | Put options by funds: $5K
0% more funds holding
Funds holding: 35 → 35 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
30% less capital invested
Capital invested by funds: $71.6M → $50.4M (-$21.2M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$311K |
| 2 |
Edgewood Management
Greenwich,
Connecticut
|
+$140K |
| 3 |
VF
Virtu Financial
New York
|
+$63K |
| 4 |
LC
Lindbrook Capital
Calabasas,
California
|
+$32.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
E
Ergoteles
New York
|
-$138K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$119K |
| 3 |
HF
HRT Financial
New York
|
-$110K |
| 4 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
-$25.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$24.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $8K | +$7.58K | +108 | +300% |
|
27
UBS Group
Zurich,
Switzerland
| $4K | -$10.7K | -152 | -67% |
|
28
First Manhattan
New York
| $4K | – | – | – |
|
29
Osaic Holdings
Scottsdale,
Arizona
| $4K | +$6.03K | +86 | New |
|
30
Morgan Stanley
New York
| $3K | -$70 | -1 | -1% |
|
31
Wells Fargo
San Francisco,
California
| $3K | +$842 | +12 | +27% |
|
32
Bank of America
Charlotte,
North Carolina
| $1K | -$982 | -14 | -54% |
|
|
APA
33
American Portfolios Advisors
Holbrook,
New York
| $836 | – | – | – |
|
34
BNP Paribas Financial Markets
Paris,
France
| $583 | -$140 | -2 | -15% |
|
|
E
35
Ergoteles
New York
| – | -$138K | -1,858 | Closed |
|
|
36
Marshall Wace
London,
United Kingdom
| – | -$119K | -1,601 | Closed |
|
|
HF
37
HRT Financial
New York
| – | -$110K | -1,486 | Closed |
|
38
Barclays
London,
United Kingdom
| – | -$7K | -93 | Closed |
|
|
GRP
39
Global Retirement Partners
San Rafael,
California
| – | -$1K | -7 | Closed |
|
AXLA Hedge Fund Activity: Q4 2021 in Review
35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q4 2021, worth a combined $50.4M — down 30% from $71.6M a quarter earlier.
Fund positioning in AXLA was balanced in Q4 2021: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 9 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $311K. The largest seller was Ergoteles, exiting entirely with an estimated $138K sold.
- 35 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $50.4M of Axcella Health Inc. Common Stock stock for Q4 2021, down 30% quarter-over-quarter.
- 5 funds opened new Axcella Health Inc. Common Stock positions in Q4 2021 and 5 closed out, a net change of 0 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q4 2021 was Fidelity Investments, an estimated $311K added.
- The largest Axcella Health Inc. Common Stock seller in Q4 2021 was Ergoteles, an estimated $138K sold.
Based on aggregated 13F filings for Q4 2021.